Abstract
The search for therapeutic candidates of memory disorders including gene targets and compounds both synthetic and natural has been a prime arena of neurobiology research. Amongst suggested therapeutic compounds, several herbal products with a long history of use in Ayurveda have gained attention in modern medicine. Ashwagandha (Withania somnifera) also referred to as “Queen of Ayurveda” is at the zenith of Ayurvedic herbs owing to its tremendous potential to recover memory decline in aging and neurodegenerative pathologies as well as enhance basal memory function of healthy individuals. Despite such promising effects, limited mechanistic evidences have hindered its acceptance in modern medicine. However, technical advances in neuroscience research over the past decade have filled-in some gaps in understanding of molecular and mechanistic biology of Ashwagandha effects. In this chapter, we highlight the studies that have deciphered the cellular and molecular mechanisms of memory enhancing potential of Ashwagandha in various disease models. Cellular targets of Ashwagandha include (i) activation of antioxidant defence system rescuing nerve cells from apoptosis, oxidative stress and DNA damage, (ii) induction of cholinergic system and (iii) up-regulation of memory linked neuroplasticity genes and neuronal arborisation. All of these molecular effects translate into increase in memory. Such multiple-module action has intrigued research to unravel upstream master regulators of Ashwagandha effects on gene expression, cell physiology and behaviour.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baitharu I, Jain V, Deep SN, Hota KB, Hota SK, Prasad D, Ilavazhagan G (2013) Withania somnifera root extract ameliorates hypobaric hypoxia induced memory impairment in rats. J Ethnopharmacol 145:431–441
Baitharu I, Jain V, Deep SN, Shroff S, Sahu JK, Naik PK, Ilavazhagan G (2014) Withanolide A prevents neurodegeneration by modulating hippocampal glutathione biosynthesis during hypoxia. PLoS One 9:e105311
Bano D, Agostini M, Melino G, Nicotera P (2011) Ageing, neuronal connectivity and brain disorders: an unsolved ripple effect. Mol Neurobiol 43:124–130
Bartsch T, Deuschl G (2010) Transient global amnesia: functional anatomy and clinical implications. Lancet Neurol 9:205–214
Bekinschtein P, Cammarota M, Medina JH (2013) BDNF and memory processing. Neuropharmacol 76:677–683
Ben Achour S, Pascual O (2010) Glia: the many ways to modulate synaptic plasticity. Neurochem Int 57:440–445
Bhattarai JP, Ah Park S, Han SK (2010) The methanolic extract of Withania somnifera ACTS on GABAA receptors in gonadotropin releasing hormone (GnRH) neurons in mice. Phytother Res 24:1147–1150
Bhattarai JP, Park SJ, Han SK (2013) Potentiation of NMDA receptors by Withania somnifera on hippocampal CA1 pyramidal neurons. Am J Chin Med 41:503–513
Bramham CR, Alme MN, Bittins M, Kuipers SD, Nair RR, Pai B, Panja D, Schubert M, Soule J, Tiron A, Wibrand K (2009) The Arc of synaptic memory. Exp Brain Res 200:125–140
Budson AE, Price BH (2005) Memory dysfunction. N Engl J Med 352:692–699
Candelario M, Cuellar E, Reyes-Ruiz JM, Darabedian N, Feimeng Z, Miledi R, Russo-Neustadt A, Limon A (2015) Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors. J Ethnopharmacol 171:264–272
Cavallaro S, D’Agata V, Manickam P, Dufour F, Alkon DL (2002) Memory-specific temporal profiles of gene expression in the hippocampus. Proc Natl Acad Sci U S A99:16279–16284
Cingolani LA, Goda Y (2008) Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy. Nat Rev Neurosci 9:344–356
Deocaris CC, Widodo N, Wadhwa R, Kaul SC (2008) Merger of ayurveda and tissue culture-based functional genomics: inspirations from systems biology. J Transl Med 6:1–8
Di Carlo M, Giacomazza D, Picone P, Nuzzo D, San Biagio PL (2012) Are oxidative stress and mitochondrial dysfunction the key players in the neurodegenerative diseases? Free Radic Res 46:1327–1338
Gautam A, Kaul SC, Thakur MK (2015) Alcoholic extract of Ashwagandha leaves protects against amnesia by regulation of Arc function. Mol Neurobiol 53:1760–1769
Gautam A, Wadhwa R, Thakur MK (2013) Involvement of hippocampal Arc in amnesia and its recovery by alcoholic extract of Ashwagandha leaves. Neurobiol Learn Mem 106:177–184
Gold PE (2006) The many faces of amnesia. Learn Mem 13:506–514
Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF, Barnes CA (2000) Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J Neurosci 20:3993–4001
Harada A, Teng J, Takei Y, Oguchi K, Hirokawa N (2002) MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction. J Cell Biol 158:541–549
Havekes R, Vecsey CG, Abel T (2012) The impact of sleep deprivation on neuronaland glial signaling pathways important for memory and synaptic plasticity. Cell Signal 24:1251–1260
Holger J (2013) Memory loss in Alzheimer’s disease. Dialogues Clin Neurosci 15:445–454
Hubka P (2006) Neural network plasticity, BDNF and behavioral interventions in Alzheimer’s disease. Bratisl Lek Listy 107:395–401
Igaz LM, Bekinschtein P, Vianna MM, Izquierdo I, Medina JH (2004) Gene expression during memory formation. Neurotox Res 6:189–204
Jansen RL, Brogan B, Whitworth AJ, Okello EJ (2014) Effects of five Ayurvedic herbs on locomotor behaviour in a Drosophila melanogaster Parkinson’s disease model. Phytother Res 28:1789–1795
Jayaprakasam B, Padmanabhan K, Nair MG (2010) Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer’s disease. Phytother Res 24:859–863
Johnson JL, Huang W, Roman G, Costa-Mattioli M (2015) TORC2: a novel target for treating age-associated memory impairment. Sci Rep 5:15193
Kidd PM (2008) Alzheimer’s disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Altern Med Rev 13:85–115
Klinkenberg I, Blokland A (2010) The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 34:1307–1350
Konar A, Shah N, Singh R, Saxena N, Kaul SC, Wadhwa R, Thakur MK (2011) Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One 6:e27265
Kuboyama T, Tohda C, Komatsu K (2005) Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 144:961–971
Kuboyama T, Tohda C, Komatsu K (2006) Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration. Eur J Neurosci 23:1417–1426
Kuboyama T, Tohda C, Komatsu K (2014) Effects of Ashwagandha roots of Withania somnifera on neurodegenerative diseases. Biol Pharm Bull 37:892–897
Kulkarni SK, Dhir A (2008) Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry 32:1093–1105
Kumar GP, Khanum F (2012) Neuroprotective potential of phytochemicals. Pharmacogn Rev 6:81–90
Kumar S, Seal CJ, Howes MJ, Kite GC, Okello EJ (2010) In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxideand beta-amyloid (1-42)-induced cytotoxicity in differentiated PC12 cells. Phytother Res 24:1567–1574
Kurapati KR, Atluri VS, Samikkannu T, Nair MP (2013) Ashwagandha (Withania somnifera) reverses beta-amyloid1-42 induced toxicity in human neuronal cells:implications in HIV-associated neurocognitive disorders (HAND). PLoS One 8:e77624
Leal G, Comprido D, Duarte CB (2013) BDNF-induced local protein synthesis and synaptic plasticity. Neuropharmacology 76:639–656
Lee Y, Silva A (2009) The molecular and cellular biology of enhanced cognition. Nat Rev Neurosci 10:126–140
Liu LF, Durairajan SS, Lu JH, Ko I, Li M (2012) In vitro screening on amyloid precursor protein modulation of plants used in Ayurvedic and traditional Chinese medicine for memory improvement. J Ethnopharmacol 141:754–760
Manjunath MJ, Muralidhara (2013) Effect of Withania somnifera supplementation on rotenone-induced oxidative damage in cerebellum and striatum of the male mice brain. Am J Chin Med 41:503–513
Mattson MP (2004) Pathways towards and away from Alzheimer’s disease. Nature 430:631–639
McKay G, Kopelman MD (2009) Psychogenic amnesia: when memory complaints are medically unexplained. Adv Psychiatr Treat 15:152–158
McKinney M, Jacksonville MC (2005) Brain cholinergic vulnerability: relevance to behavior and disease. Biochem Pharmacol 70:1115–1124
Mishra LC, Singh BB, Dagenais S (2000) Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 5:334–346
Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul ADT (2007) Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 40:163–173
Morrison JH, Baxter MG (2012) The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci 13:240–250
RajaSankar S, Manivasagam T, Sankar V, Prakash S, Muthusamy R, Krishnamurti A, Surendran S (2009) Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson’s disease model mouse. J Ethnopharmacol 125:369–373
Sankar SR, Manivasagam T, Krisnamurt A, Ramanathan M (2007) The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: An analysis of behavioural and biochemical variables. Cell Mol Biol Lett 12:473–481
Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221:555–563
Schulze ET, Geary EK, Susmaras MT, Paliga JT, Maki PM, Little DM (2011) Anatomical correlates of age-related working memory declines. J Aging Res 1–9
Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, Hamel E, Khanna P, Jain SC, Thakur SS, Ravindranath V (2012) Withania somnifera reverses Alzheimer’s disease pathology by enhancing low-density lipoprotein receptor related protein in liver. Proc Natl Acad Sci USA 109:3510–3515
Shukla KK, Mahdi AA, Mishra V, Rajender S, Sankhwar SN, Patel D, Das M (2011) Withania somnifera improves semen quality by combating oxidative stress and cell death and improving essential metal concentrations. Reprod Biomed Online 22:421–427
Silva AF, Aguiar MS, Carvalho OS, Santana Lde N, Franco EC, Lima RR, Siqueira NV, Feio RA, Faro LR, Gomes-Leal W (2013) Hippocampal neuronal loss, decreased GFAP immunoreactivity and cognitive impairment following experimental intoxication of rats with aluminum citrate. Brain Res 1491:23–33
Singh N, Bhalla M, de Jager P, Gilca M (2011) An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med 8:208–213
Singh RH, Narsimhamurthy K, Singh G (2008) Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontol 9:369–374
Soman S, Korah PK, Jayanarayanan S, Mathew J, Paulose CS (2012) Oxidative stress induced NMDA receptor alteration leads to spatial memory deficits in temporal lobe epilepsy: ameliorative effects of Withania somnifera and Withanolide A. Neurochem Res 37:1915–1927
Tohda C (2008) Overcoming several neurodegenerative diseases by traditional medicines: the development of therapeutic medicines and unravelling pathophysiological mechanisms. Yakugaku Zasshi 128:1159–1167
Tohda C, Joyashiki E (2009) Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET. Br J Pharmacol 157:1427–1440
Ven Murthy MR, Ranjekar PK, Ramassamy C, Deshpande M (2010) Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha. Cent Nerv Syst Agents Med Chem 10:238–246
Waterhouse EG, Xu B (2009) New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci 42:81–89
Winters M (2006) Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern Med Rev 11:269–277
Yamada K, Nabeshima T (2003) Brain-derived neurotrophic factor/TrkB signaling in memory processes. J Pharmacol Sci 91:267–270
Young EJ, Briggs SB, Miller CA (2015) The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use. CNS Neurol Disord Drug Targets 14:731–737
Zhao J, Nakamura N, Hattori M, Kuboyama T, Tohda C, Komatsu K (2002) Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities. Chem Pharm Bull 50:760–765
Acknowledgements
The work cited in this article from authors’ laboratory has been supported by grants from the Department of Science and Technology (SR/SO/HS-54/2008) and Department of Biotechnology (BT/PR3996/MED/97/57/2011), Government of India.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Konar, A., Thakur, M.K. (2017). Cellular and Molecular Targets Underpinning Memory Enhancement by Ashwagandha. In: Kaul, S., Wadhwa, R. (eds) Science of Ashwagandha: Preventive and Therapeutic Potentials. Springer, Cham. https://doi.org/10.1007/978-3-319-59192-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-59192-6_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59191-9
Online ISBN: 978-3-319-59192-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)